Prognosis and improved outcomes in major depression: a review.

Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. · 2019

Read Prognosis and improved outcomes in major depression: a review. by Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6447556.txt.

Description

Kraus and co-authors review what predicts outcome in major depression and which plans might finally improve it. No tool in routine care yet sorts patients by likely course or predicts who will respond. How long depression goes untreated tracks with worse results, so spotting it early leads the advice. Early gains themselves predict response and full recovery, while other illnesses stretch the episode out.

Candidate biomarkers span memory-center volume, cingulate activity, BDNF, and inflammatory markers such as interleukin-6 and C-reactive protein, none ready for daily care. Gene tests for drug-processing enzymes may help set doses. A stepwise plan orders first- to third-line treatments, with shock therapy, newer stimulation methods, and ketamine held for cases that resist the rest.

Catalog record

CREATORKraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE91 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6447556

Browse the full library · About the Tower of Babel